Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 22.59M | 34.89M | 33.60M | 40.59M | 49.06M |
Total Depreciation and Amortization | 27.57M | 27.08M | 28.14M | -18.54M | 27.31M |
Total Amortization of Deferred Charges | -- | -- | -- | 46.60M | -- |
Total Other Non-Cash Items | 3.45M | 10.18M | 11.89M | 17.09M | 3.29M |
Change in Net Operating Assets | -12.49M | 12.20M | -9.74M | -10.24M | 1.33M |
Cash from Operations | 41.12M | 84.35M | 63.89M | 75.50M | 80.99M |
Capital Expenditure | -10.12M | -6.82M | -9.17M | -17.98M | -16.44M |
Sale of Property, Plant, and Equipment | 0.00 | 1.79M | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 1.25M | 0.00 | -12.51M | 9.17M | 0.00 |
Cash from Investing | -8.87M | -5.03M | -21.68M | -8.81M | -16.44M |
Total Debt Issued | 38.00M | -- | -- | 0.00 | 0.00 |
Total Debt Repaid | -8.00M | 0.00 | -19.00M | -70.00M | -58.00M |
Issuance of Common Stock | 14.87M | 5.54M | 25.10M | 22.93M | 18.33M |
Repurchase of Common Stock | -100.34M | -76.64M | -4.98M | -402.00K | -168.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -12.58M | -12.74M | -12.69M | -12.63M | -12.58M |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -68.05M | -83.84M | -11.57M | -60.10M | -52.42M |
Foreign Exchange rate Adjustments | -1.08M | -5.47M | 5.12M | 5.28M | -2.35M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -36.88M | -9.99M | 35.75M | 11.88M | 9.78M |